MarketWatchCenter·
The Wegovy pill is still dominating the GLP-1 pill market
It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.
Read at MarketWatch →
Markets · 1 sources covering this
The Wegovy pill is still dominating the GLP-1 pill market
It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/8b6b1641b2710e69a65848eecd7f905d51bee802" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="The Wegovy pill is still dominating the GLP-1 pill market"></iframe>
